Dr. Mangalmurti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Old Lancaster Rd
Suite 410
Bryn Mawr, PA 19010Phone+1 610-527-1165Fax+1 610-527-6611
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Interventional Cardiology, 2008 - 2009
- UPMC Medical EducationFellowship, Cardiovascular Disease, 2005 - 2008
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2006
- NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2005
- New York University School of MedicineClass of 2001
Certifications & Licensure
- NJ State Medical License Current
- PA State Medical License 2005 - 2024
- NY State Medical License 2008 - 2011
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 60 citationsIntravascular Lithotripsy for Treatment of Calcified Lower Extremity Arterial Stenosis: Initial Analysis of the Disrupt PAD III Study:George L. Adams, Nicolas W. Shammas, Sarang Mangalmurti, Nelson L. Bernardo, William Miller
Journal of Endovascular Therapy. 2020-04-03 - 19 citationsIntravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial.Gunnar Tepe, Marianne Brodmann, William Bachinsky, Andrew Holden, Thomas Zeller
Journal of the Society for Cardiovascular Angiography & Interventions. 2022-05-19 - 67 citationsIntravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial.Gunnar Tepe, Marianne Brodmann, Martin Werner, William B. Bachinsky, Andrew Holden
JACC. Cardiovascular Interventions. 2021-06-28
Press Mentions
- Sectoral Asset Management Makes $9M Investment into Cagent VascularJune 17th, 2021
- Shockwave Medical Announces VIVA20 Investor Update and Conference Call Discussing Third Quarter 2020 ResultsOctober 22nd, 2020
- ‘I Thought I Was Going to Die’: First-of-Its-Kind Treatment Uses Sound Waves to Treat Common Heart ConditionJune 17th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: